CompanyGraph
At a glance
- Depends onDownstream position: depends on 12 industries, supplies 7
- ScaleMarket cap is $3.56B, above the global median of $1.18B
- FinancialsAltman Z-Score 7.01: safe zone
- Interpretations6 currently firing — 6
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.18%Below 5Y avg (2.67%)
Annual Rate
USD 2.68Paid quarterly
Payout Ratio
29.1%Sustainable
Consecutive Growth
21 yrStrong track record
Paying Dividends
25 yr
Payback Period
87.9 yr
Last Ex-Dividend
Sep 30, 2026
Next Payment
Oct 30, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.56BUSDvs all stocks (USD)
Trailing P/E
25.52xvs Medical Care Facilities peers
Revenue (TTM)
1.56BUSDvs all stocks (USD)
Profit Margin
9.00%vs Medical Care Facilities peers
Beta
0.6310xvs all stocks
52-Week Change
85.65%vs all stocks
Forward Annual Dividend Yield
1.18%vs all stocks
Market Capitalization
3.56BUSDvs all stocks (USD)
Enterprise Value
3.39BUSDvs all stocks (USD)
Trailing P/E
25.52xvs Medical Care Facilities peers
Forward P/E
528.74xvs Medical Care Facilities peers
PEG Ratio
0.3718xvs Medical Care Facilities peers
Price to Sales (TTM)
2.28xvs Medical Care Facilities peers
Price to Book (MRQ)
3.17xvs Medical Care Facilities peers
Enterprise to Revenue
2.17xvs Medical Care Facilities peers
Enterprise to EBITDA
17.79xvs Medical Care Facilities peers
Gross Margin
40.71%vs Medical Care Facilities peers
Profit Margin
9.00%vs Medical Care Facilities peers
Operating Margin
11.99%vs Medical Care Facilities peers
Return on Assets (TTM)
5.84%vs Medical Care Facilities peers
Return on Equity (TTM)
13.27%vs Medical Care Facilities peers
Revenue (TTM)
1.56BUSDvs all stocks (USD)
Revenue per Share (TTM)
100.34USDUpdated Sep 28, 2026Quarterly Revenue Growth
8.80%vs Medical Care Facilities peers
Gross Profit (TTM)
615.63MUSDvs all stocks (USD)
EBITDA (TTM)
199.43MUSDvs all stocks (USD)
Net Income (TTM)
140.26MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
70.00%vs Medical Care Facilities peers
Operating Cash Flow (TTM)
188.81MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
63.17MUSDvs all stocks (USD)
Forward Annual Dividend Rate
2.68USDUpdated Sep 28, 2026Forward Annual Dividend Yield
1.18%vs all stocks
Trailing Annual Dividend Rate
2.59USDUpdated Sep 28, 2026Trailing Annual Dividend Yield
1.14%vs all stocks
5-Year Average Dividend Yield
2.67%vs all stocks
Payout Ratio
29.10%vs Medical Care Facilities peers
Minority Interest (Equity)
5.74MUSDFY2025 · Dec 31, 2025Revenue
1.52BUSDFY2025 · Dec 31, 2025Cost of Goods Sold
921.08MUSDFY2025 · Dec 31, 2025Gross Profit
596.70MUSDFY2025 · Dec 31, 2025Operating Income
128.35MUSDvs all stocks (USD)
Pre-tax Income
162.43MUSDFY2025 · Dec 31, 2025Income Tax Expense
39.83MUSDFY2025 · Dec 31, 2025Net Income
122.61MUSDFY2025 · Dec 31, 2025EBIT
168.80MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
183.33MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
46.23MUSDFY2025 · Dec 31, 2025Other Operating Expenses
377.20MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
9.84MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
6.37MUSDFY2025 · Dec 31, 2025EPS (Basic)
7.76USDFY2025 · Dec 31, 2025EPS (Diluted)
7.67USDFY2025 · Dec 31, 2025Basic Shares Outstanding
15.47MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
15.47MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
122.61MUSDFY2025 · Dec 31, 2025Minority Interests (P&L)
-2.59MUSDFY2025 · Dec 31, 2025Operating Cash Flow
197.64MUSDFY2025 · Dec 31, 2025Free Cash Flow
161.19MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
112.19MUSDFY2025 · Dec 31, 2025Income Tax Paid
24.72MUSDFY2025 · Dec 31, 2025Interest Paid
7.03MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
122.61MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
44.92MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
6.48MUSDFY2025 · Dec 31, 2025Stock-based Compensation
4.40MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-3.68MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
-2.73MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
25.64MUSDFY2025 · Dec 31, 2025Capital Expenditures
-36.45MUSDFY2025 · Dec 31, 2025Net Acquisitions
-5.63MUSDFY2025 · Dec 31, 2025Purchase of Investments
-65.19MUSDFY2025 · Dec 31, 2025Sale of Investments
72.89MUSDFY2025 · Dec 31, 2025Other Investing Activity
512.00KUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-33.86MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025Long-term Debt Payments
-97.00MUSDFY2025 · Dec 31, 2025Common Stock Repurchase
-14.73MUSDFY2025 · Dec 31, 2025Common Dividends Paid
-38.70MUSDFY2025 · Dec 31, 2025Other Financing Charges
265.00KUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-135.96MUSDFY2025 · Dec 31, 2025Shares Outstanding
15.66MSharesUpdated Sep 28, 2026Float Shares
12.71MSharesUpdated Sep 28, 2026Shares Short
683.17KSharesUpdated Sep 28, 2026Short Ratio
7.35daysvs all stocks
Short % of Shares Outstanding
5.38%vs all stocks
% Held by Insiders
18.83%vs all stocks
% Held by Institutions
66.77%vs all stocks
Total Cash (MRQ)
210.19MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
13.42USDUpdated Sep 28, 2026Total Debt (MRQ)
31.41MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.0278xvs Medical Care Facilities peers
Current Ratio (MRQ)
1.86xvs Medical Care Facilities peers
Book Value per Share (MRQ)
71.66USDUpdated Sep 28, 2026Total Assets
1.53BUSDvs all stocks (USD)
Total Current Assets
461.82MUSDFY2025 · Dec 31, 2025Total Liabilities
451.90MUSDFY2025 · Dec 31, 2025Total Non-current Assets
1.06BUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
198.27MUSDFY2025 · Dec 31, 2025Total Current Liabilities
253.63MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
92.83MUSDFY2025 · Dec 31, 2025Other Short-term Investments
162.97MUSDFY2025 · Dec 31, 2025Accounts Receivable
139.00MUSDFY2025 · Dec 31, 2025Inventory
7.79MUSDFY2025 · Dec 31, 2025Accounts Payable
22.77MUSDFY2025 · Dec 31, 2025Short-term Debt
41.11MUSDFY2025 · Dec 31, 2025Other Current Liabilities
25.98MUSDFY2025 · Dec 31, 2025Long-term Debt
45.96MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
24.21MUSDFY2025 · Dec 31, 2025Common Stock (Book)
155.00KUSDFY2025 · Dec 31, 2025Retained Earnings
832.98MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
1.07BUSDvs all stocks (USD)
52-Week Low
116.42USDUpdated Sep 28, 202652-Week High
239.29USDUpdated Sep 28, 202652-Week Change
85.65%vs all stocks
Beta
0.6310xvs all stocks
50-Day MA
223.93USDUpdated Sep 28, 2026200-Day MA
182.62USDUpdated Sep 28, 2026Avg 10-Day Volume
126.71KSharesUpdated Sep 28, 2026Avg 30-Day Volume
108.90KSharesUpdated Sep 28, 2026Diluted EPS (TTM)
8.91USDUpdated Sep 28, 2026Other Income / Expense
30.61MUSDFY2025 · Dec 31, 20256 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
How does this company use capital?
Working Capital Pattern
What customers owe has grown three years running, while it clears stock quickly and pays suppliers quickly.
Reads
FCF Ratios Elevated
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
Three Turnover Ratios Elevated
Collects fast, clears inventory fast, and pays suppliers fast too.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
How is this stock valued?
High Retained Earnings With Profitability And Equity
Profits kept in the business fund much of what it owns, after five straight profitable years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 7.01: safe zoneNotable
Altman Z-Score: 7.01
High earnings qualityNotable
Earnings Quality Score: 0.90
Supply Chain
Downstream position: depends on 12 industries, supplies 7Notable
Outgoing: 7.00Incoming: 12.00
High connectivity hub: 19 industry connectionsNotable
Total Connections: 19.00
Scale
Market cap is $3.56B, above the global median of $1.18BNotable
Market cap (USD): 3,560,774,767Global Median: 1,180,223,658.953
Revenue is $1.56B, above the global median of $548.88MNotable
Revenue (USD): 1,559,020,032Global Median: 548,883,780.48
Levered free cash flow is $63.17M, above the global median of $18.73MNotable
Levered free cash flow (USD): 63,169,624Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Chenbro Micom Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
SEB SA
Tier 1ProductionThroughput-Bound ConversionFlowInterface
Addsino Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Wistron NeWeb Corp.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Universal Display Corporation
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Inner Mongolia Erods Resources Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Mesaieed Petrochemical Holding Company Q.P.S.C.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Kontoor Brands Inc.
Tier 1ProductionThroughput-Bound ConversionFlowAttention
Shenzhen Senior Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Sinotruk Jinan Truck Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Companies that share active interpretations — structural patterns currently present in both stocks.
Stride, Inc.
5 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityFCF Ratios ElevatedMulti-Year Revenue, Profit, And Income GrowthWorking Capital Pattern
Promotora y Operadora de Infraestructura S.A.B. de C.V.
5 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityThree Turnover Ratios ElevatedFCF Ratios ElevatedMulti-Year Revenue, Profit, And Income Growth
Promotora y Operadora de Infraestructura, S.A.B. de C.V.
5 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityThree Turnover Ratios ElevatedFCF Ratios ElevatedMulti-Year Revenue, Profit, And Income Growth